Q32021

Item Name Sales Qty. Sales Value Target Qty.

FORTEO COL INJ 250MCG/ML 2.4MLX1PEND EG 1,564 4,848,400 4,100

OLUMIANT TAB 2MG X28BLCD EG 41 502,127 25
OLUMIANT TAB 4MG X28BLCD QRR1 117 1,432,899 551
Bone 6,783,426
HUMALOG KWIKPEN 100U/ML 3ML X5PEND EG 2,458 1,103,936 11,000
HUMALOG MIX50 KWIKPEN 100U/ML X5PEND EG 7,061 3,890,396 13,000
HUMALOG 100U/ML 3ML X5CART EG 7,235 2,516,040 21,000
HUMALOG PYTHIA TRIS 200U/ML X5PEND QR 538 388,327 1,518
HUMULIN M3 100U/ML 3ML X5CART EG 23,397 3,006,979 65,000
Diabetes 1 10,905,678
HUMALOG MIX25 KWIKPEN 100U/ML X5PEND EG 4,553 2,508,563 11,500
TRULICITY 0.75MG/0.5ML X4PEND QR RET 25 40,100 100
TRULICITY 1.5MG/0.5ML X4PEND QR RET 5,640 9,046,558 12,000
Diabetes 2 11,595,221
HUMALOG MIX 75/25 100U/ML 3ML X5CART EG 489 200,011 2,000
HUMULIN N INJ 100UML 3ML X5CART EG 705 90,606 2,500
HUMULIN R 100U/ML 3ML X5CART EG 3,568 458,559 9,000
Non promoted - Diabetes 749,176
ALIMTA FINJ 500MG 50ML X1VIAL EG 599 4,191,802 310
ALIMTA FINJ 500MG 50ML X1VIAL EG UPA 0 0 1,260
GEMZAR FINJ 1G 50ML X1VIAL EG 1,921 1,725,519 3,300
GEMZAR FINJ 1G 50ML X1VIAL EG UPA 0 0 18,700
GEMZAR FINJ 200MG 10ML X1VIAL EG 4,161 931,149 2,800
GEMZAR FINJ 200MG 10ML X1VIAL EG UPA 0 0 4,200
CYRAMZA INJ 100MG 10ML ENR1 96 877,344 40
CYRAMZA INJ 100MG 10ML ENR1 UPA 0 0 220
CYRAMZA INJ 500MG 50ML ENR1 55 2,394,645 65
CYRAMZA INJ 500MG 50ML ENR1 UPA 0 0 150
VERZENIO TAB 100MG X14X1BLCD QR 7 90,300 54
VERZENIO TAB 100MG X14X1BLCD QR UPA 0 0 17
VERZENIO TAB 150MG X14X1BLCD QR 369 4,760,100 605
VERZENIO TAB 150MG X14X1BLCD QR UPA 0 0 316
VERZENIO TAB 200MG X14X1BLCD QR 25 322,500 13
Oncology 15,293,358
CYMBALTA 30 MG 28 CAP 15,721 2,650,399 27,000
CYMBALTA 60 MG 28 CAP 11,463 2,643,250 19,500
PROZAC 20 MG 14 CAP 55,896 2,973,664 98,000
STRATTERA 10 MG 28 CAP 310 134,462 551
STRATTERA 18 MG 28 CAP 385 166,993 560
STRATTERA 25 MG 28 CAP 677 293,648 1,217
STRATTERA 40 MG 28 CAP 914 396,447 1,404
STRATTERA 60 MG 28 CAP 699 303,190 1,976
ZYPREXA 10 MG 7 TAB 11,590 1,517,592 17,700
ZYPREXA 10mg VELTOTAB 28Tab 2,114 986,158 3,582
ZYPREXA 5 MG 14 TAB 7,952 1,041,233 17,000
EMGALITY 120MG 1ML X1 PEND AM 12 93,600 127
CNS 13,200,635
CIALIS TAB 20MG X2BLCD EG 130,823 11,917,975 178,108
CIALIS TAB 20MG X4BLCD EG 64,822 11,810,567 105,207
Consumer Team 23,728,542
Total Lilly 82,256,036
Target Value Ratio

12,710,000 38.1%
306,175 164.0%
6,748,097 21.2%
19,764,272 34.3%
4,940,320 22.3%
7,162,610 54.3%
7,302,960 34.5%
1,095,692 35.4%
8,353,800 36.0%
28,855,382 37.8%
6,336,155 39.6%
160,400 25.0%
19,248,000 47.0%
25,744,555 45.0%
818,040 24.4%
321,300 28.2%
1,156,680 39.6%
2,296,020 32.6%
2,169,380 193.2%
8,817,480 0.0%
2,964,192 58.2%
11,201,300 0.0%
626,584 148.6%
850,920 0.0%
365,560 240.0%
880,000 0.0%
2,830,035 84.6%
2,550,000 0.0%
696,600 13.0%
221,850 0.0%
7,804,500 61.0%
 4,123,800 0.0%
167,700 192.3%
46,269,901 33.1%
4,551,930 58.2%
4,496,505 58.8%
5,213,600 57.0%
238,996 56.3%
242,900 68.7%
527,874 55.6%
608,985 65.1%
857,090 35.4%
2,317,638 65.5%
1,670,967 59.0%
2,225,980 46.8%
990,600 9.4%
23,943,065 55.1%
16,225,639 73.5%
19,168,715 61.6%
35,394,354 67.0%
182,267,550 45.1%
 1- July closing for all distributors. 2- Aug. 20th

Item Name BU Sales Qty. Sales Value Target Qty.

Thiotacid Compound 300 - 30Cap 53,305 2,455,759 130,000

Thiotacid 600 mg - 20 tab 213,524 9,837,047 440,000
Thiotacid 600 mg 10 cap HI 0 0 0
Thiotacid Compound/600 - 20Cap 342,979 15,801,039 720,000
Thiotacid 300 mg 30 tab PM 67,476 3,012,800 130,000
Thiotacid 300 mg - 30Cap AM 15,197 15,197 0
Zanoglide 30/2 30tab 32,297 793,535 67,000
Zanoglide 30/4mg 30 Tablet 122,480 3,260,414 247,767
Amloveran 5/5 30 Tab 6,721 371,552 16,100
Amloveran 5/10 mg 30 Tab 466 27,670 1,000
Amloveran 10/5 mg 30 Tab 1,196 96,646 1,000
Amloveran 10/10 mg 30 Tab 2,953 257,974 6,200
AMLOVERAN PLUS 10/2.5/10 MG 30 TAB.N 942 115,724 2,200
Amloveran plus (5/1.25/5) 457 36,491 6,500
Gliptus 50 mg 30 tabs 52,171 3,391,533 100,401
Gliptus plus 50-1000 mg 30 tabs 208,354 14,788,963 480,000
Gliptus Plus 50mg / 850mg 30 tab 81,174 5,761,727 100,401
Thiotacid 600 mg 20 tab A.M 0 0 906,100
Thiotacid Comp 300 30Cap AM 0 0 652,320
CVD 60,024,070
Mellitofix MET 12.5/500 30tab 10,281 1,084,088 24,462
Mellitofix MET 5/1000 30tab 4,256 381,246 9,831
Mellitofix MET 12.5/1000 30tab 44,631 5,208,792 94,149
Prandaglim 6.25mg f.c.tab. 53 2,387 398
Prandaglim 25MG F.C 30 TAB 64 8,518 1,750
Prandaglim MET 12.5/1000 FC30 T 113 7,635 2,700
Prandaglim MET 12.5/500 FC30 T 151 9,893 1,716
Prandaglim Plus 25 / 15 mg f.c.tablets 909 130,282 11,280
Prandaglim Plus 25 / 30 mg f.c.tablets 644 97,575 9,120
CVD1 / Diabetes 6,930,416
Mellitofix 25mg Film Coated Tablet 4,794 971,743 20,000
 Mellitofix 10 mg 30 Tab. 3,591 560,626 9,530
Apixatrack 2.5 MG 20 TAB -35 -4,288 0
Apixatrack 2.5 MG 30 TAB 3,450 633,971 26,000
Apixatrack 5 MG 10 TAB. -25 -1,531 0
Apixatrack 5 MG 30 TAB. 2,431 446,730 22,000
CVD1 / Cardio 2,607,251
CVD1 9,537,668
Marvitense 40/10/12.5 MG 30 tab 1,665 85,227 9,000
Marvitense 40/10/25 MG 30 tab 9,060 482,307 24,000
Marvitense 40/5/12.5 MG 30 tab 9,575 431,304 24,000
Marvitense 20/5/12.5 MG 30 tab 8,752 268,794 25,000
Marvitense 40/5/25 MG 30 tab 3,235 152,343 8,000
DIAFLOZIMET 5/500 MG 30 TAB 1,393 154,023 3,500
DIAFLOZIMET 5/1000 MG 30 TAB 1,667 184,320 14,500
DIAFLOZIMET 5/1000 MG 30 TAB UPA 670 39,007 0
Diaflozimet 10/500 XR tablets 1,411 223,177 5,000
Diaflozimet 10/1000 XR tablets_x000D_ 10,751 1,700,484 29,000
CVD2 3,720,988
Simvastimibe 10/40 30 tab 69 3,532 300
Simvastimibe 10/20 mg 30 Tab 771 36,309 1,200
Savapran 5mg tab. -72 -5,172 0
Savapran 5mg tab. 30 tab 54 5,818 200
Savapran 7.5mg tab. 126 9,417 250
CVD Non-promoted 49,904
Repatoxaban 15 mg 3 strips 0 0 2,000
Repatoxaban 20 mg 3 strips 0 0 3,500
General medicine

CVD New launches 0

CVD 73,332,629
Cymbatex 60 mg 30 Cap 17,270 2,528,258 35,000
Cymbatex 30 mg 30 Cap 66,319 7,513,606 189,385
Cymbatex 20 mg 30 Cap 26,489 2,277,917 50,000
Donifoxate 40mg 30 tab 14,911 745,442 28,500
Donifoxate 80mg 30 tab 19,538 1,143,438 36,500
DURAFOS 2 ML 1 AMP. 38,479 420,188 120,000
Genuphil advance 7,755 824,277 50,000
Genuphil Syrup 21,670 665,537 35,000
Genuphil 50 Tab 12,943 988,716 0
 GENUPHIL ORIGINAL 50 TAB. 181,988 12,950,624 400,000
Genuphil 50 Tab HI 33,864 1,818,496 90,000
Genuphil 30 Tab -3 -122 0
General BPR 31,876,377
Acti-Colla C 10 Sachets 59,060 5,100,418 120,000
Acti-Colla C 30 Sachets 8,016 2,076,784 18,000
Acticolla advance 0 0 40,000
Venlatrope 50 MG 20 TAB 136 5,941 15,000
Venlatrope 50 MG 30 TAB 7,333 480,456 0
Venlatrope 100 MG 20 TAB 583 33,104 7,500
VENLATROPE 100 MG 30 TAB 1,508 128,444 0
HYDROXYTIOD 200 MG 20 TAB. 16,535 481,497 90,000
HYDROXYTIOD 200 MG 10 TAB. UPA 0 0 30,000
Arthfree 10 Tab 0 0 0
Arthfree 30 Tab 70,821 7,733,650 120,000
Arthfree 30 Tab AM 0 0 0
Arthfree 10 Tab MOH 125,021 2,400,403 315,000
BPR 1 18,440,696
Diacerein 30 caps 52,282 3,300,622 150,000
Anselacox 60 MG 30 Tab 19,541 1,970,509 40,000
Anselacox 90 MG 30 Tab 40,079 4,287,645 120,000
Repatoxaban 10 Tab 2,558 157,124 6,000
BPR 2 9,715,901
Moxiflox 400 mg 10 Tab 62,787 6,342,114 125,000
Moxiflox 400 mg 10 Tab UPA 1,193 29,467 1,113
revemact 6mg UPA 0 0 12,753
Sinomarin® C & F 30 ML 601 45,481 4,000
Sinomarine Adults 125 ML-NP 9,206 761,174 25,000
Sinomarine ENT 2,833 254,089 6,000
Flix Nasal Spray 99,219 2,112,371 300,000
Avipravir 200 mg 40 Tab. 2,328 1,290,154 10,000
Floxabact 5 tab 500 mg -6 -64 0
Floxabact 10 tab 500 mg 24,732 720,195 115,000
Floxabact 10 tab 500 mg UPA 5,575 37,074 10,000
Bosentadin 62.5 mg 10 Tab 290 138,349 600
Bosentadin 125 mg 10 Tab 2,438 1,163,090 3,600
Moxiflox Solution for I.V. infusion UPA 3,360 127,680 20,000
Moxiflox Solution for I.V. infusion 10,070 828,169 20,000
Respiratory 13,849,343
Unipricort 20 mg 20 Tab ODT 1,297 42,490 5,000
Bonprove 150 mg - 3 tab 2,660 119,819 4,800
ZITHROPRO 500 MG 3 TAB 2,103 32,912 25,000
Inhalex 47 6,472 0
Tamilavir 75 MG 10 Cap. 331 28,916 5,000
MSM 30 Tab 48,614 723,569 80,000
Zeficam 8mg 20 tab 7,534 92,555 9,500
BPR non promoted 1,046,733
BPR new launch 0
BPR 74,929,049
General medicine Unit 148,261,678
Lamidine 150 mg 10 tab 8,511 309,799 7,500
Lamidine 150 mg 10 tab UPA 6,364 211,603 22,000
Lamidine 100mg 30 tab 2,988 195,773 6,850
LAMIDINE 100 MG 30 TAB FOR UPA 200 11,494 0
Tecavir 0.5mg 30 Tab 3,217 2,107,777 4,000
Tecavir 0.5mg 30 Tab UPA 740 47,456 16,000
Tecavir 1mg 30 Tab 1,269 1,247,173 2,000
Tecavir 1 mg 20 tab -4 -2,563 0
Tecavir 1mg 30 Tab UPA 374 31,977 10,000
Rolaximine 550mg 30 tab -10 -1,031 0
Nucleobuvir Velpa 400/100 28 tab 168 302,442 300
Lamidine 100mg 30 tab AM 0 0 40,755
Lamidine 150 mg 10 tab AM 3,720 3,720 0
Lamidine 150 mg 30 tab AM 0 0 0
Tecavir 0.5mg 30 Tab AM -25,080 -25,080 0
Tecavir 0.5mg 20 Tab AM 0 0 0
Tecavir 1mg 20 Tab AM 0 0 0
Tecavir 1 mg 30 Tab AM 0 0 0
TENOFENAMIDE 25 MG 30 TAB. 702 236,440 1,100
Cloviralex 600 mg - 30 Cap 4 1,881 0
Tenaviron 300 mg 30tab 5,286 1,385,354 10,000
Tenaviron 300 mg 30tab AM 52,250 52,250 0
Tenaviron 300 mg 30tab UPA 5,730 694,075 22,500
Hepa 6,810,540
 Ravemantine 30 tab 10mg 2,254 196,909 5,000
Olanza 20 Tab 5 Mg 7,948 325,471 15,000
Paroxetine 12.5 MG CR 30Tab 15,720 617,984 32,000
Paroxetine 25 MG CR 30 Tab 36,461 1,831,508 67,500
Paroxetine 37.5 MG CR 30 Tab 3,662 215,940 7,500
Neural Science 3,187,811
Donazil 5 MG - 30 Tab 7,973 342,818 14,000
Ramixole .25 MG, 30 tab 26,308 592,521 50,000
Ramixole .25 MG, 30 tab A.M 11,385 11,385 0
Ramixole 1 MG, 30 tab 15,752 1,032,070 25,000
Ramixole 1 MG, 30 tab AM 0 0 0
Zonivan 50 MG 20 CAP -39 -1,171 500
Zonivan 100 MG 20 CAP 91 3,478 1,000
Oxigrex 300mg - 30 tab (Horus) 538 20,654 1,000
Geriatric Science 2,001,755
Specialty

Brimodrops eye drops 4,138 96,586 9,500

Moxiflox Eye Drops 48,998 551,773 82,000
Optest eye drops 5 ml 31,942 418,562 50,000
Alcaftapro Eye Drops 4,515 294,279 8,500
Cornifresh eye drops 15,702 347,214 27,000
Tekliva 2.5 ml. eye drops 996 34,802 1,550
Tekliva plus 2.5 ml. eye drops 10,522 612,801 9,500
Optilubric .32% Eye drops 30 unit 15,671 481,298 30,000
Artofenac 0.09% eye drops 1,455 25,563 5,000
MYDRITHALM 0.5% UNI-DOSE 20 UNIT 7,492 245,436 7,000
MYDRITHALM 1% UNI-DOSE 20 UNIT 13,212 432,823 13,000
Moxiflox Eye Drops AM 0 0 0
Optest eye drops 5 ml AM 32,190 32,190 0
Ophtha 3,573,328
Fodavir 30 tab -46 -7,535 0
Carnivita 5 Ampoule 1,107 30,221 0
Nucleobuvir Velpa 28 Tab MOH 0 0 789
Fodavir 30 tab AM 0 0 0
Prazolam 0.50 mg 30 tab AM 0 0 0
Prazolam 0.25 mg 30 tab AM 0 0 0
Nucleobuvir 400 mg 28 Tablet -57 -25,080 0
Nucleobuvir 400 28tab 3boxes AM 0 0 0
 Nucleobuvir 400 mg 28 Tablet AM 0 0 0
Specialty /Tender_Non Promoted -2,394
Metronidazole vial 0 0 3,000
Remdesivir 100 MG 1 Vial 0 0 0
Remdesivir 100 MG 1 Vial MOH 0 0 0
Remdesivir 100 MG 1 Vial NP 10,761 3,843,829 25,000
Remdesivir 100 MG 1 Vial UPA NP 7,106 1,918,620 20,000
Dexamethasone Phosphate 8 MG/ML 5 amp. 0 0 500
Dexamethasone Phosphate 4 MG/ML 5 amp. 0 0 0
Cefotaxime 1 gm 0 0 10,000
Cefotaxime 1 gm UPA 19,997 113,983 430,000
Meropenem 1G 0 0 20,000
Meropenem 1G UPA 64,931 3,522,507 40,000
Levofloxacin - Eva pharma 500mg/100ml UPA 22,203 263,772 35,000
Levofloxacin sterile sol. For I.V. infusion 100 ml 30 810 3,900
Hospital 9,663,520
Nausetron 0.5 MG 1 CAP -49 -7,876 230
Nausetron .05MG/1ML 5ML IV MOH 8,276 151,037 12,500
Nausetron .05MG/1ML 5ML IV 99 18,306 2,400
Oncology 161,467
Specialty Unit 25,396,028
Esomelodan 20 mg 20 tab 8,709 374,463 15,500
Esomelodan 40 mg - 20 tab. 58,609 2,759,892 130,000
Esomelodan 40 mg - 20 tab. AM 169,539 169,539 202,500
Garopride 30 tab 41,692 853,638 85,000
Esomelodan 40 mg 3 vial 2,004 155,237 7,000
Armowake 50mg 20 tab. 21,915 942,341 35,100
Armowake 50mg 10 tab. -270 -5,804 0
Conventin 400 - 30Cap AM 260,416 260,416 2,150,040
Conventin 100 - 30Cap AM 990 990 591,660
Conventin 100 mg 30 cap PM 141,655 2,861,707 400,000
Conventin 300 mg, 30 cap 496,801 21,700,260 1,200,000
Conventin 400 mg 30 cap PM 493,492 29,100,229 1,100,000
Conventin 300 - 30Cap AM 0 0 1,509,550
Conventin 400 mg 10 cap HI 149,918 1,271,304 528,307
Conventin 100 mg 10 cap HI 111,344 306,196 281,441
Myofen 30 caps 214,666 3,956,288 575,000
 Ossofortin Original D3 5000 IU 57,919 2,586,077 110,000
LIMITLESS TURMERIC 500 MG 60 CAP 3,681 584,687 10,000
Milga Advance 30 TAB. 469,145 17,954,171 1,050,000
Milga 30 Tab 12,081 277,041 0
Milga 40 Tab 1,665,933 50,937,559 3,500,000
Milga 30 Tab AM 0 0 0
Family Advisors 137,046,232
Biofreeze gel 93,987 9,746,449 65,000
Biofreeze 2oz Roll on 7,446 772,149 7,500
Biofreeze 2oz Spray 20,954 2,172,928 12,000
NRG 10 Original Sol. 60Ml 6bottle -7 -697 200
NRG 10 Original Sol. 60Ml 12bottle -16 -3,186 200
NRG 10 SUGAR FREE SOLUTION 60 ML ( Box 6 4 399 151
BOTTLES )
NRG 10 SUGAR FREE SOLUTION 60 ML (Box 12 2 399 60
bottles)
NRG 10 Original Sol. 60Ml 24bottles 0 0 100
NRG 10 SUGAR FREE SOLUTION 60 ML (Box 24 bottles) 0 0 141
Vegan Protein 0 0 900
Chocolate Balls with probiotics for adults 275 23,749 3,000
Slimmer 50_2nd_NP 12,471 289,956 40,500
Slimmer 100 14,749 627,055 39,150
Slimmer 300_2nd_NP 964 99,900 2,160
Family Advisors NS 13,729,099
Trospamexin 20 mg - 20 tab. 23,084 661,698 52,000
Flopadex 4 mg 20 Cap 5,848 223,507 8,000
Flopadex 8 mg 20 Cap 296 15,084 0
Flopadex 8 mg 30 Cap 48,473 3,705,270 80,000
Valysernex 1000 mg - 20 Tab 3,669 454,072 6,500
Descar Gel 10 GM 627 113,988 1,800
Hairtonic 30 Tabs 17,619 944,021 35,000
Fusiderm cream 249,312 2,722,481 310,000
Fusiderm oint 5,390 58,857 55,000
LIMITLESS ZINC 1,505 57,595 20,000
Diamonrecta 5 mg 30 Tab 62,173 7,956,273 105,000
Diamonrecta 5 mg 20 Tab -11 -938 0
URO Derma 16,911,909
Solitract 5 mg 30 Tab 7,873 464,790 12,000
Solitract 10 mg 30 Tab 3,079 238,509 6,000
 Hihaem 100 mg 30 capsules 8,457 259,733 25,000
Cyclogest 200 MG 1,467 139,745 3,500
Cyclogest 400 MG 14,306 1,892,680 33,000
Carnivita advance men (30/6) 0 0 7,700
Carnivita advance women (30/6) 0 0 5,200
Carnivita Forte - 30Cap 129,667 8,185,874 250,000
Prostanorm 30 Caps 18,085 1,202,288 40,000
Prostetrol 30tab 14,857 456,292 24,000
Fertility 12,839,911
Zofatrone 4mg / 2mg ampoule 20,547 740,431 50,000

Family Medicine
Zofatrone 8mg / 4mg ampoule 30,496 1,598,478 62,000
Limitless Kids Multivitamins iron 30 balls 1,382 73,445 8,000
Limitless Kids Multivitamins Calcuim 30 balls 534 28,379 6,000
Limitless kids probiotics 30 chocolate balls 176 11,692 3,500
Limitless C-Zinc 30 Tab. 14,651 448,613 80,000
Micazole 20 g 2,435 11,301 19,980
Micazole 40 g 26,817 183,025 59,400
Deslorat Syrup 1,785 11,695 0
Vendexine 157,740 1,049,657 445,500
France Lait AR 0 0 0
France Lait Premature 57 6,011 500
FRANCE LAIT Premium 1 1 74 0
FRANCE LAIT L.F 14 1,289 500
France Lait Premium 2 330 24,583 500
Sinomarine Mini 30 ML_NP 8,225 564,809 16,000
Sinomarine Children 7,502 625,515 18,000
Pedia Care 5,378,998
Sinlerg 20 tab 68,514 981,976 180,000
Tritospot cream 15G 254,751 2,086,410 500,000
Tritospot cream 30G 23,525 337,171 45,000
Paroxetine 30 Tab (Horus) AM 0 0 0
Paroxetine 30 Tab (Horus) 21,205 955,179 48,600
Virecta 9 tab 383,208 10,723,117 760,000
Powerecta 20 mg 3 tab 20 294 0
Powerecta 20 mg 4 tab 186,150 3,652,609 460,000
Powerecta 10mg 4tab ODT 2Strip 701 8,612 0
Powerecta 10mg 2tab ODT 3Strip 60,660 1,862,868 230,000
 Stopadol Extra 20 Tab 1,738 14,234 0
Stopadol 500 mg 20 Tab 68,414 398,169 200,000
Manovipercaine plus 15ml spray 61,860 1,182,144 105,000
Laxeol 20 Tabs 66,508 430,971 135,000
Laxeol - Bi Tabs 25 strips Horus 1,986 160,965 6,750
Tardanza 60 mg. 3 Tab 20,917 1,370,482 43,000
Diamonrecta 2 tabs 18,439 629,231 42,000
Diamonrecta 4 tabs 33,696 2,299,752 87,000
Diamonrecta 20 mg 6 tabs 182 18,632 0
Consumer Team 27,112,815
Chromax 60 caps 103,080 5,386,649 250,000
Orly 30 Cap 198,910 14,118,630 422,000
LIMITLESS WOMAN MAX 30 TABLETS 4,707 390,341 50,000
LIMITLESS MAN MAX 30 TABLETS 4,928 425,581 14,000
LIMITLESS VITAMIN C 500 MG 20 TAB 432 12,403 8,000
LIMITLESS C-ZINC PLUS 20 TAB 4,691 179,524 50,000
Limitless Sleep aid (30/6) 0 0 5,000
LIMITLESS LACTOFERRIN 100 MG 14 SACHET 1,179 63,925 18,500
limitless lactoferrin 30 sachets 321 31,740 3,000
Limitless Naturals 20,608,794
Vitaferrol 30 cap 37,831 697,130 0
Prazolam 0.25 MG 30 Tab 2,888 29,566 0
Prazolam 0.50 MG 30 Tab 7,606 97,333 0
MANOVIPERCAINE 10% SPRAY -3 -25 0
Deslorat 5 MG - 20 tab 3,457 50,334 0
Acnetrox 1% topical cream 12,752 208,877 0
Tinox 15 g cream 46,420 316,816 0
Mycoverex 15 mg Cream 519 5,101 0
Carnivita Forte Syrup 3,635 87,327 0
Moov_N.P 273,681 1,540,992 710,000
Moov Massage cream 40gr M.O.H. 151,510 1,050,722 160,000
Nitora 30 Tab 17,589 261,776 0
Calster 500 mg 30tab 447 7,096 0
Ossofortin 0.25mg 98,749 2,224,123 80,000
Ossofortin 1.25mg -3 -111 0
OSSOFORTIN ORIGINAL D2 10,000 IU 30 TAB.N 3,400 91,093 0
Water for injection 5 ml 0 0 0
Family Medicine / Non-promoted 6,668,150
Family Medicine / New launch 0
Family Medicine Unit 240,295,909
Total Lines 413,953,615
Cloxide 30 Caps_NP 17,351 76,972 29,263
Heel Forte Oint 1,128 5,774 2,165
Flumol syrup 14,277 80,388 29,929

Non-promoted Items
Vitaferrol 120 ml elixir 14,882 91,412 21,406
Metograine 612 3,342 7,731
Fusiderm gel -36 -393 0
Ulcfree 20 cap 63 903 291
Stopain 20 cap -165 -574 0
Soprol 10 mg 30 Tab -41 -862 0
Hairtone 40 cap -32 -830 0
Lamizidine 0 0 9,537
Non-promoted Items 256,131
Total Company 414,209,746

Item Name Line Sales Qty. Sales Value Target Qty.

Ambisome 10 Vial 3,973 6,098,555 8,500

Vosevi Botlle 28 tab MOH 32 136,000 0
Gilead

Viread 30 tab 232 124,120 750

Vemlidy bottle 30 tab 41 37,925 300
Trauvada 30 tab 0 0 71,000
Gilead 6,396,600

Item Name BU Sales Qty. sales Value Target Qty.

Neuth Anti Aging Eye Cr. 18ml 117 25,683 1,068

Neuth Lightening System Cr 30ml 267 65,201 763
Neuth Lightening System Day30ml 6 1,465 1,525
Neuth Reflection System 50 ml -6 -1,091 450
Neuth Anti Ageing System Cr 50ml 101 29,445 763
Neuth Gold System Cr. 50ml 131 51,670 1,220
Neuth DNA Sun Protection 50ml 68 13,294 450
Neuth Anti Aging hand Cr. 50ml 17 3,440 366
Neuth
 Neuth Protection System L100ml -5 -978 450
Neuth Cleansing System Gel150ml 65 7,803 610
Neuth AA Facial Wash 200 ml 170 23,089 458

Neuth
Neuth AA Purifying Exfoliator150ml 99 14,940 610
Neuth AA Sunscreen SPF50-50 ml 92 17,986 366
Neuth Anti-Acne Resolving 30 ml 123 21,937 610
Neuth Anti-Acne Toner 200 ml 185 28,553 458
Neuth Anti-Hair Loss Sh. 55 ml 74 10,152 610
Neuth Anti-Hair Loss Sh. 200 ml 83 11,842 610
Neuth Anti-hair loss Cond. 200ml 76 13,033 610
Neuth Anti-hair loss Treat. 6ml 81 52,785 458
NEUTH Arnica Reviving System Gel 50ML 84 12,388 458
NEUTH Arnica Reviving System Spray 140ML 41 7,453 458
Neuth Makeup Removal 200ml -32 -4,280 366
Total Neuth 405,812

Specialty Merged products

Item Name Sales Value
Lamidine 150 313,519
Lamidine 100 207,267
Tenaviron 2,131,678
Tecavir 0.5 2,082,697
Tecavir 1 1,244,610
Armowake 936,537

FM Merged products
Item Name Sales Value
Diamonrecta 7,955,335
Powerecta 3,652,904
 Q32021

ing for all distributors. 2- Aug. 20th for AM, Akhnaton, UCP, Pharma Overseas & Ibn Sina.

Ratio on Aug. Ratio on Aug.

Target Value Ratio Points Sales Points Target Points 21st 11th
5,989,100 41.0% 3.0 7,367,276 17,967,300 41.0% 34.1%
20,270,800 48.5% 3.0 29,511,140 60,812,400 48.5% 39.9%
0 0.0% 2.0 0 0 0.0% 0.0%
33,170,400 47.6% 3.0 47,403,116 99,511,200 47.6% 36.9%
5,804,500 51.9% 4.0 12,051,201 23,218,000 51.9% 44.3%
0 0.0% 1.0 15,197 0 0.0% 0.0%
1,646,190 48.2% 3.0 2,380,604 4,938,570 48.2% 36.1%
6,595,558 49.4% 3.0 9,781,241 19,786,673 49.4% 38.1%
890,048 41.7% 2.0 743,104 1,780,097 41.7% 30.9%
59,378 46.6% 2.0 55,339 118,755 46.6% 34.9%
80,808 119.6% 2.0 193,293 161,616 119.6% 104.8%
541,632 47.6% 2.0 515,947 1,083,264 47.6% 40.3%
270,270 42.8% 2.0 231,447 540,540 42.8% 28.7%
519,025 7.0% 2.0 72,982 1,038,050 7.0% 2.6%
6,526,878 52.0% 5.0 16,957,667 32,634,391 52.0% 41.3%
34,070,400 43.4% 4.0 59,155,851 136,281,600 43.4% 35.9%
7,126,463 80.8% 4.0 23,046,909 28,505,852 80.8% 67.3%
906,100 0.0% 2.0 0 1,812,200 0.0% 0.0%
652,320 0.0% 2.0 0 1,304,640 0.0% 0.0%
125,119,870 48.0% 209,482,315 431,495,147 48.5% 39.3%
2,579,420 42.0% 3.0 3,252,264 7,738,260 42.0% 34.6%
880,651 43.3% 4.0 1,524,985 3,522,605 43.3% 34.4%
10,987,941 47.4% 3.0 15,626,375 32,963,824 47.4% 38.7%
17,928 13.3% 2.0 4,775 35,856 13.3% 11.6%
232,908 3.7% 2.0 17,035 465,815 3.7% 2.1%
182,431 4.2% 1.0 7,635 182,431 4.2% 3.3%
112,432 8.8% 2.0 19,787 224,865 8.8% 7.2%
1,616,706 8.1% 2.0 260,564 3,233,412 8.1% 5.8%
1,381,817 7.1% 2.0 195,150 2,763,634 7.1% 5.5%
17,992,234 38.5% 20,908,570 51,130,701 40.9% 33.3%
4,054,000 24.0% 3.0 2,915,229 12,162,000 24.0% 19.1%
 1,487,824 37.7% 4.0 2,242,505 5,951,294 37.7% 29.5%
0 0.0% 2.0 -8,575 0 0.0% 0.0%
4,777,760 13.3% 2.0 1,267,943 9,555,520 13.3% 10.4%
0 0.0% 2.0 -3,063 0 0.0% 0.0%
4,042,808 11.0% 2.0 893,460 8,085,616 11.0% 8.3%
14,362,392 18.2% 7,307,498 35,754,430 20.4% 16.0%
32,354,626 29.5% 28,216,068 86,885,132 32.5% 26.2%
460,688 18.5% 2.0 170,453 921,375 18.5% 16.1%
1,277,640 37.7% 2.0 964,615 2,555,280 37.7% 32.0%
1,081,080 39.9% 2.0 862,609 2,162,160 39.9% 32.7%
767,813 35.0% 2.0 537,588 1,535,625 35.0% 31.5%
376,740 40.4% 2.0 304,687 753,480 40.4% 34.1%
386,995 39.8% 4.0 616,094 1,547,980 39.8% 28.5%
1,603,265 11.5% 4.0 737,281 6,413,060 11.5% 8.9%
0 0.0% 2.0 78,015 0 0.0%
790,850 28.2% 4.0 892,708 3,163,400 28.2% 22.9%
4,586,930 37.1% 4.0 6,801,935 18,347,720 37.1% 25.8%
11,332,000 32.8% 11,965,984 37,400,080 32.0% 23.8%
15,356 23.0% 1.0 3,532 15,356 23.0% 22.0%
56,512 64.2% 1.0 36,309 56,512 64.2% 60.2%
0 0.0% 5.0 -25,858 0 0.0% 0.0%
21,548 27.0% 5.0 29,089 107,740 27.0% 20.0%
18,685 50.4% 5.0 47,087 93,427 50.4% 44.0%
112,101 44.5% 90,159 273,035 33.0% 28.2%
478,091 0.0% 2.0 0 956,183 0.0% 0.0%
895,781 0.0% 0.5 0 447,891 0.0% 0.0%
1,373,873 0.0% 0 1,404,073 0.0% 0.0%
170,292,469 43.1% 249,754,526 557,457,467 44.8% 36.1%
5,123,869 49.3% 5.0 12,641,292 25,619,344 49.3% 40.5%
21,456,374 35.0% 5.0 37,568,028 107,281,868 35.0% 29.5%
4,299,750 53.0% 5.0 11,389,584 21,498,750 53.0% 42.8%
1,424,801 52.3% 4.0 2,981,769 5,699,202 52.3% 39.6%
2,136,126 53.5% 3.0 3,430,315 6,408,378 53.5% 41.7%
1,310,400 32.1% 2.0 840,376 2,620,800 32.1% 23.2%
5,314,400 15.5% 3.0 2,472,831 15,943,200 15.5% 0.2%
1,074,938 61.9% 2.0 1,331,073 2,149,875 61.9% 51.0%
0 0.0% 4.0 3,954,862 0 0.0% 0.0%
28,464,800 45.5% 4.0 51,802,497 113,859,200 45.5% 33.3%
4,833,000 37.6% 4.0 7,273,985 19,332,000 37.6% 12.2%
0 0.0% 3.0 -367 0 0.0% 0.0%
75,438,456 42.3% 135,686,246 320,412,617 42.3% 31.3%
10,363,200 49.2% 3.0 15,301,254 31,089,600 49.2% 38.4%
4,663,440 44.5% 3.0 6,230,351 13,990,320 44.5% 33.5%
4,118,660 0.0% 3.0 0 12,355,980 0.0% 0.0%
655,200 0.9% 3.0 17,822 1,965,600 0.9% 0.8%
0 0.0% 3.0 1,441,368 0 0.0% 0.0%
425,880 7.8% 3.0 99,313 1,277,640 7.8% 6.8%
0 0.0% 3.0 385,332 0 0.0% 0.0%
2,620,816 18.4% 3.0 1,444,491 7,862,448 18.4% 14.7%
507,300 0.0% 0.5 0 253,650 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
13,104,000 59.0% 5.0 38,668,249 65,520,000 59.0% 42.9%
0 0.0% 1.0 0 0 0.0% 0.0%
6,048,000 39.7% 2.0 4,800,806 12,096,000 39.7% 34.0%
42,506,496 43.4% 68,388,984 146,411,238 46.7% 35.3%
9,469,688 34.9% 4.0 13,202,488 37,878,750 34.9% 26.8%
4,033,600 48.9% 4.0 7,882,038 16,134,400 48.9% 37.8%
12,837,600 33.4% 4.0 17,150,581 51,350,400 33.4% 25.9%
368,550 42.6% 2.0 314,248 737,100 42.6% 39.1%
26,709,438 36.4% 38,549,355 106,100,650 36.3% 28.1%
12,626,250 50.2% 4.0 25,368,454 50,505,000 50.2% 38.1%
27,491 107.2% 3.0 88,401 82,473 107.2% 25.2%
242,307 0.0% 2.0 0 484,614 0.0% 0.0%
302,702 15.0% 2.0 90,962 605,405 15.0% 10.8%
2,067,065 36.8% 2.0 1,522,348 4,134,130 36.8% 28.3%
538,138 47.2% 2.0 508,179 1,076,275 47.2% 34.5%
6,387,000 33.1% 3.0 6,337,113 19,161,000 33.1% 25.4%
5,541,900 23.3% 5.0 6,450,769 27,709,500 23.3% 12.4%
0 0.0% 3.0 -193 0 0.0% 0.0%
3,348,800 21.5% 4.0 2,880,780 13,395,200 21.5% 14.6%
66,500 55.8% 0.5 18,537 33,250 55.8% 43.3%
286,241 48.3% 4.0 553,398 1,144,962 48.3% 39.5%
1,717,443 67.7% 4.0 4,652,361 6,869,772 67.7% 62.6%
760,000 16.8% 2.0 255,360 1,520,000 16.8% 102.4%
 1,644,825 50.3% 3.0 2,484,507 4,934,475 50.3% 36.0%
35,556,662 39.0% 51,210,977 131,656,056 38.9% 29.8%
163,800 25.9% 0.5 21,245 81,900 25.9% 21.6%
216,216 55.4% 2.0 239,639 432,432 55.4% 47.1%
391,250 8.4% 2.0 65,824 782,500 8.4% 6.4%
0 0.0% 1.0 6,472 0 0.0% 0.0%
436,800 6.6% 2.0 57,832 873,600 6.6% 5.2%
1,190,720 60.8% 2.0 1,447,139 2,381,440 60.8% 44.2%
116,708 79.3% 2.0 185,110 233,415 79.3% 64.2%
2,515,494 41.6% 2,023,259 4,785,287 42.3% 31.8%
0 0.0% 0 0 0.0% 0.0%
182,726,545 41.0% 295,858,821 709,365,848 41.7% 31.4%
353,019,014 42.0% 545,613,347 1,266,823,314 43.1% 33.5%
273,000 113.5% 4.0 1,239,198 1,092,000 113.5% 97.2%
731,500 28.9% 5.0 1,058,015 3,657,500 28.9% 11.4%
448,812 43.6% 4.0 783,093 1,795,248 43.6% 34.4%
0 0.0% 4.0 45,976 0 0.0% 0.0%
2,620,800 80.4% 5.0 10,538,887 13,104,000 80.4% 54.4%
1,026,080 4.6% 5.0 237,281 5,130,400 4.6% 1.8%
1,965,600 63.4% 5.0 6,235,864 9,828,000 63.4% 49.7%
0 0.0% 5.0 -12,816 0 0.0% 0.0%
855,000 3.7% 4.0 127,908 3,420,000 3.7% 3.4%
0 0.0% 0.0 0 0 0.0% 0.0%
540,075 56.0% 3.0 907,326 1,620,225 56.0% 48.3%
40,755 0.0% 4.0 0 163,020 0.0% 0.0%
0 0.0% 3.0 11,160 0 0.0% 0.0%
0 0.0% 3.0 0 0 0.0% 0.0%
0 0.0% 5.0 -125,400 0 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
370,491 63.8% 4.0 945,761 1,481,964 63.8% 49.9%
0 0.0% 5.0 9,405 0 0.0% 0.0%
2,620,800 52.9% 4.0 5,541,415 10,483,200 52.9% 41.7%
0 0.0% 4.0 208,998 0 0.0% 0.0%
2,725,425 25.5% 5.0 3,470,375 13,627,125 25.5% 10.7%
14,218,338 47.9% 31,222,444 65,402,682 47.7% 33.1%
436,800 45.1% 4.0 787,636 1,747,200 45.1% 35.5%
614,250 53.0% 3.0 976,412 1,842,750 53.0% 49.6%
1,257,984 49.1% 3.0 1,853,951 3,773,952 49.1% 37.1%
3,390,660 54.0% 3.0 5,494,523 10,171,980 54.0% 41.2%
442,260 48.8% 3.0 647,821 1,326,780 48.8% 39.6%
6,141,954 51.9% 9,760,342 18,862,662 51.7% 40.6%
601,965 56.9% 2.0 685,636 1,203,930 56.9% 47.4%
1,126,125 52.6% 4.0 2,370,082 4,504,500 52.6% 41.2%
0 0.0% 2.0 22,770 0 0.0% 0.0%
1,638,000 63.0% 5.0 5,160,351 8,190,000 63.0% 45.6%
0 0.0% 2.0 0 0 0.0% 0.0%
15,015 -7.8% 2.0 -2,342 30,030 -7.8% -5.2%
38,220 9.1% 1.0 3,478 38,220 9.1% 8.2%
38,391 53.8% 0.0 0 0 0.0% 0.0%
3,457,716 57.9% 8,239,975 13,966,680 59.0% 44.3%
221,744 43.6% 1.0 96,586 221,744 43.6% 34.4%
923,423 59.8% 1.0 551,773 923,423 59.8% 49.5%
655,200 63.9% 2.0 837,125 1,310,400 63.9% 51.9%
554,019 53.1% 1.0 294,279 554,019 53.1% 46.2%
597,051 58.2% 1.0 347,214 597,051 58.2% 47.0%
54,163 64.3% 1.0 34,802 54,163 64.3% 51.0%
553,280 110.8% 1.0 612,801 553,280 110.8% 101.6%
921,390 52.2% 1.0 481,298 921,390 52.2% 43.4%
87,850 29.1% 1.0 25,563 87,850 29.1% 21.6%
229,320 107.0% 1.0 245,436 229,320 107.0% 81.1%
425,880 101.6% 1.0 432,823 425,880 101.6% 76.2%
0 0.0% 3.0 0 0 0.0% 0.0%
0 0.0% 3.0 96,570 0 0.0% 0.0%
5,223,320 68.4% 4,056,270 5,878,520 69.0% 57.3%
0 0.0% 5.0 -37,674 0 0.0% 0.0%
0 0.0% 2.0 60,442 0 0.0% 0.0%
749,550 0.0% 0.5 0 374,775 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
0 0.0% 2.0 0 0 0.0% 0.0%
0 0.0% 2.0 0 0 0.0% 0.0%
0 0.0% 3.0 -75,240 0 0.0% 0.0%
0 0.0% 0.5 0 0 0.0% 0.0%
 0 0.0% 0.5 0 0 0.0% 0.0%
749,550 -0.3% -52,472 374,775 -14.0% -19.5%
48,000 0.0% 0.0 0 0 0.0% 0.0%
0 0.0% 5.0 0 0 0.0% 0.0%
0 0.0% 5.0 0 0 #DIV/0! #DIV/0!
8,930,000 43.0% 3.0 11,531,486 26,790,000 43.0% 26.3%
5,400,000 35.5% 3.0 5,755,860 16,200,000 35.5% 35.0%
9,000 0.0% 2.0 0 18,000 0.0% 0.0%
0 0.0% 2.0 0 0 #DIV/0! #DIV/0!
80,000 0.0% 0.0 0 0 0.0% 0.0%
2,451,000 4.7% 0.5 56,991 1,225,500 4.7% 4.7%
2,000,000 0.0% 3.0 0 6,000,000 0.0% 0.0%
2,170,000 162.3% 2.0 7,045,014 4,340,000 162.3% 61.9%
415,625 63.5% 0.5 131,886 207,813 63.5% 0.0%
105,300 0.8% 1.0 810 105,300 0.8% 0.8%
21,608,925 44.7% 24,522,047 54,886,613 44.7% 28.2%
36,968 -21.3% 1.0 -7,876 36,968 -21.3% -19.6%
228,125 66.2% 2.0 302,074 456,250 66.2% 64.8%
443,789 4.1% 1.0 18,306 443,789 4.1% 3.3%
708,881 22.8% 312,504 937,006 33.4% 32.4%
52,108,684 48.7% 78,061,111 160,308,938 48.7% 34.0%
666,461 56.2% 4.0 1,497,851 2,665,845 56.2% 47.8%
6,121,700 45.1% 3.0 8,279,677 18,365,100 45.1% 36.0%
202,500 83.7% 3.0 508,617 607,500 83.7% 83.7%
1,740,375 49.0% 2.0 1,707,277 3,480,750 49.0% 33.5%
542,246 28.6% 1.0 155,237 542,246 28.6% 27.4%
1,509,300 62.4% 2.0 1,884,682 3,018,600 62.4% 53.5%
0 0.0% 0.0 0 0 0.0% 0.0%
2,150,040 12.1% 3.0 781,249 6,450,120 12.1% 12.1%
591,660 0.2% 3.0 2,970 1,774,980 0.2% 0.2%
8,080,800 35.4% 3.0 8,585,121 24,242,400 35.4% 27.9%
52,416,000 41.4% 5.0 108,501,300 262,080,000 41.4% 32.3%
64,864,800 44.9% 4.0 116,400,914 259,459,200 44.9% 35.8%
1,509,550 0.0% 3.0 0 4,528,650 0.0% 0.0%
4,480,043 28.4% 2.0 2,542,609 8,960,087 28.4% 19.2%
773,963 39.6% 0.0 0 0 0.0% 0.0%
10,597,250 37.3% 2.0 7,912,576 21,194,500 37.3% 24.6%
 4,911,500 52.7% 4.0 10,344,310 19,646,000 52.7% 43.6%
1,588,400 36.8% 2.0 1,169,374 3,176,800 36.8% 18.9%
40,183,500 44.7% 4.0 71,816,683 160,734,000 44.7% 37.2%
0 0.0% 4.0 1,108,166 0 0.0% 0.0%
107,016,000 47.6% 5.0 254,687,795 535,080,000 47.6% 35.2%
0 0.0% 2.0 0 0 0.0% 0.0%
309,946,088 44.2% 597,886,407 1,336,006,778 44.8% 34.6%
6,740,500 144.6% 4.0 38,985,796 26,962,000 144.6% 133.3%
777,750 99.3% 4.0 3,088,596 3,111,000 99.3% 87.9%
1,244,400 174.6% 3.0 6,518,784 3,733,200 174.6% 145.4%
19,930 -3.5% 2.0 -1,395 39,860 -3.5% -2.0%
39,828 -8.0% 2.0 -6,372 79,656 -8.0% -5.5%
15,047 2.6% 2.0 797 30,094 2.6% 2.6%
11,957 3.3% 0.0 0 0 0.0% 0.0%
31,941 0.0% 2.0 0 63,882 0.0% 0.0%
56,200 0.0% 1.0 0 56,200 0.0% 0.0%
209,255 0.0% 3.0 0 627,764 0.0% 0.0%
259,080 9.2% 3.0 71,247 777,240 9.2% 8.5%
941,645 30.8% 1.0 289,956 941,645 30.8% 25.0%
1,664,470 37.7% 1.0 627,055 1,664,470 37.7% 28.4%
223,843 44.6% 1.0 99,900 223,843 44.6% 37.9%
12,235,846 112.2% 49,674,363 38,310,853 129.7% 117.4%
1,490,580 44.4% 2.0 1,323,395 2,981,160 44.4% 36.3%
305,760 73.1% 3.0 670,521 917,280 73.1% 63.9%
0 0.0% 3.0 45,252 0 0.0% 0.0%
6,115,200 60.6% 3.0 11,115,811 18,345,600 60.6% 48.5%
804,440 56.4% 1.0 454,072 804,440 56.4% 44.5%
327,240 34.8% 5.00 569,939 1,636,200 34.8% 28.7%
1,875,300 50.3% 3.0 2,832,063 5,625,900 50.3% 37.1%
3,385,200 80.4% 2.0 5,444,963 6,770,400 80.4% 55.2%
600,600 9.8% 1.0 58,857 600,600 9.8% 9.5%
765,400 7.5% 5.0 287,977 3,827,000 7.5% 5.9%
13,436,850 59.2% 5.0 39,781,366 67,184,250 59.2% 45.5%
0 0.0% 5.0 -4,692 0 0.0% 0.0%
29,106,570 58.1% 62,579,526 108,692,830 57.6% 44.3%
708,435 65.6% 2.0 929,579 1,416,870 65.6% 54.6%
464,783 51.3% 2.0 477,018 929,565 51.3% 45.2%
 767,813 33.8% 1.0 259,733 767,813 33.8% 29.2%
333,410 41.9% 5.0 698,726 1,667,050 41.9% 38.5%
4,365,900 43.4% 5.0 9,463,399 21,829,500 43.4% 38.2%
1,227,626 0.0% 3.0 0 3,682,879 0.0% 0.0%
725,416 0.0% 3.0 0 2,176,247 0.0% 0.0%
15,782,500 51.9% 2.0 16,371,748 31,565,000 51.9% 44.1%
2,659,200 45.2% 2.0 2,404,575 5,318,400 45.2% 36.0%
737,100 61.9% 2.0 912,585 1,474,200 61.9% 51.6%
27,772,182 46.2% 31,517,364 70,827,524 44.5% 38.1%
1,801,800 41.1% 5.0 3,702,155 9,009,000 41.1% 34.3%
3,249,792 49.2% 5.0 7,992,391 16,248,960 49.2% 40.9%
425,152 17.3% 2.0 146,889 850,304 17.3% 14.1%
318,864 8.9% 2.0 56,757 637,728 8.9% 6.7%
232,505 5.0% 3.0 35,075 697,515 5.0% 4.2%
2,449,600 18.3% 3.0 1,345,839 7,348,800 18.3% 14.3%
92,727 12.2% 0.0 0 0 0.0% 0.0%
405,405 45.1% 0.5 91,513 202,703 45.1% 38.0%
0 0.0% 0.0 0 0 0.0% 0.0%
2,964,522 35.4% 2.0 2,099,314 5,929,044 35.4% 27.0%
0 0.0% 1.0 0 0 0.0% 0.0%
52,731 11.4% 1.0 6,011 52,731 11.4% 5.8%
0 0.0% 1.0 74 0 0.0% 0.0%
46,035 2.8% 1.0 1,289 46,035 2.8% 2.0%
37,247 66.0% 1.0 24,583 37,247 66.0% 62.6%
1,098,720 51.4% 2.0 1,129,619 2,197,440 51.4% 40.5%
1,500,840 41.7% 2.0 1,251,031 3,001,680 41.7% 33.4%
14,675,940 36.7% 17,882,540 46,259,186 38.7% 31.5%
2,579,850 38.1% 2.0 1,963,951 5,159,700 38.1% 24.8%
4,095,000 51.0% 1.0 2,086,410 4,095,000 51.0% 34.4%
644,963 52.3% 2.0 674,342 1,289,925 52.3% 43.2%
0 0.0% 3.0 0 0 0.0% 0.0%
2,189,187 43.6% 2.0 1,910,357 4,378,374 43.6% 37.4%
21,266,700 50.4% 4.0 42,892,467 85,066,800 50.4% 38.9%
0 0.0% 3.0 883 0 0.0% 0.0%
9,026,060 40.5% 3.0 10,957,828 27,078,181 40.5% 30.4%
0 0.0% 4.0 34,447 0 0.0% 0.0%
7,063,300 26.4% 4.0 7,451,473 28,253,200 26.4% 16.6%
 0 0.0% 1.0 14,234 0 0.0% 0.0%
1,164,000 34.2% 1.0 398,169 1,164,000 34.2% 22.8%
2,006,550 58.9% 2.0 2,364,287 4,013,100 58.9% 48.2%
874,800 49.3% 2.0 861,943 1,749,600 49.3% 40.4%
547,088 29.4% 3.0 482,896 1,641,263 29.4% 24.7%
2,817,360 48.6% 4.0 5,481,926 11,269,440 48.6% 37.6%
1,433,250 43.9% 5.0 3,146,153 7,166,250 43.9% 34.4%
5,937,750 38.7% 5.0 11,498,758 29,688,750 38.7% 30.0%
0 0.0% 5.0 93,161 0 0.0% 0.0%
61,645,857 44.0% 92,313,687 212,013,582 43.5% 33.0%
13,064,250 41.2% 3.0 16,159,948 39,192,750 41.2% 35.0%
29,953,560 47.1% 2.0 28,237,260 59,907,120 47.1% 37.5%
4,146,400 9.4% 2.0 780,683 8,292,800 9.4% 6.2%
1,209,040 35.2% 3.0 1,276,743 3,627,120 35.2% 25.3%
229,680 5.4% 3.0 37,208 689,040 5.4% 3.5%
1,913,500 9.4% 3.0 538,572 5,740,500 9.4% 6.7%
498,000 0.0% 0 0 0.0% 0.0%
1,003,070 6.4% 3.0 191,775 3,009,210 6.4% 4.8%
296,640 10.7% 3.0 95,221 889,920 10.7% 7.7%
52,314,140 39.4% 47,317,411 121,348,460 39.0% 31.5%
0 0.0% 1.5 1,045,694 0 0.0% 0.0%
0 0.0% 3.0 88,698 0 0.0% 0.0%
0 0.0% 3.0 291,999 0 0.0% 0.0%
0 0.0% 1.0 -25 0 0.0% 0.0%
0 0.0% 2.0 100,667 0 0.0% 0.0%
0 0.0% 1.0 208,877 0 0.0% 0.0%
0 0.0% 1.5 475,224 0 0.0% 0.0%
0 0.0% 2.0 10,201 0 0.0% 0.0%
0 0.0% 1.0 87,327 0 0.0% 0.0%
3,997,740 38.5% 1.0 1,540,992 3,997,740 38.5% 31.9%
1,109,600 94.7% 1.0 1,050,722 1,109,600 94.7% 53.6%
0 0.0% 2.0 523,553 0 0.0% 0.0%
0 0.0% 1.5 10,644 0 0.0% 0.0%
1,801,840 123.4% 2.0 4,448,247 3,603,680 123.4% 120.1%
0 0.0% 0.0 0 0 0.0% 0.0%
0 0.0% 3.0 273,278 0 0.0% 0.0%
0 0.0% 0.0 0 0 0.0% 0.0%
 6,909,180 96.5% 10,156,098 8,711,020 116.6% 101.0%
0 0.0% 0 0 0.0% 0.0%
514,605,803 46.7% 909,327,395 1,942,170,233 46.8% 36.7%
919,733,501 45.0% 1,533,001,853 3,369,302,485 45.5% 35.4%
129,818 59.3% 0.0 0 0 0.0% 0.0%
11,082 52.1% 0.0 0 0 0.0% 0.0%
168,519 47.7% 0.0 0 0 0.0% 0.0%
131,486 69.5% 0.0 0 0 0.0% 0.0%
42,211 7.9% 0.0 0 0 0.0% 0.0%
0 0.0% 2.0 -786 0 0.0% 0.0%
4,171 21.6% 2.0 1,806 8,342 21.6% 19.9%
0 0.0% 0.0 0 0 0.0% 0.0%
0 0.0% 3.0 -2,586 0 0.0% 0.0%
0 0.0% 1.0 -830 0 0.0% 0.0%
419,628 0.0% 3.0 0 1,258,884 0.0% 0.0%
906,915 28.2% -2,396 1,267,226 -0.2% -0.1%
920,640,416 45.0% 1,532,999,457 3,370,569,711 45.5% 35.4%

Target Value Ratio

13,770,000 44.3%
0 0.0%
419,250 29.6%
255,000 14.9%
69,580,000 0.0%
84,024,250 7.6%

Target Value Ratio

234,327 11.0%
186,203 35.0%
372,405 0.4%
81,801 -1.3%
222,299 13.2%
481,205 10.7%
87,975 15.1%
74,064 4.6%
 87,975 -1.1%
73,224 10.7%
62,138 37.2%
92,055 16.2%
71,553 25.1%
108,794 20.2%
70,611 40.4%
83,686 12.1%
87,035 13.6%
104,609 12.5%
298,139 17.7%
67,472 0.0%
83,164 0.0%
48,956 -8.7%
3,079,688 13.2%

Ratio on Aug.
Target Value Ratio Sales Points Target Points 21st
273,000 114.84% 1,250,358 1,092,000 114.5%
489,567 42.34% 829,069 1,958,268 42.3%
5,346,225 39.87% 9,220,787 24,110,325 38.2%
2,620,800 79.47% 10,413,487 13,104,000 79.5%
1,965,600 63.32% 6,223,048 9,828,000 63.3%
1,509,300 62.05% 1,884,682 3,018,600 62.4%

Target Value Ratio Sales Points Target Points Ratio on Aug.

21st
13,436,850 59.21% 39,776,674 67,184,250 59.2%
9,026,060 40.47% 10,958,711 27,078,181 40.5%
Ratio on Aug. Ratio on July Ratio on July
4th 20th 11th
28.0% 11.9% 7.7%
31.8% 16.5% 9.4%
0.0% 0.0% 0.0%
29.3% 14.2% 8.2%
35.3% 18.8% 11.2%
0.0% 0.0% 0.0%
28.4% 14.3% 7.5%
30.9% 15.9% 8.0%
23.3% 15.5% 8.9%
12.0% -25.4% -0.9%
80.0% 59.1% 31.3%
28.7% 16.4% 9.0%
23.7% 1.1% 0.0%
0.6% 0.0% 0.0%
33.2% 20.5% 12.3%
28.8% 15.8% 8.1%
60.4% 17.1% 6.9%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
31.9% 15.8% 8.6%
27.4% 15.0% 8.1%
29.3% 15.6% 9.8%
29.7% 16.4% 9.3%
11.1% 14.1% 1.8%
2.6% 1.8% 0.2%
2.3% 4.0% 1.6%
5.5% 4.7% 1.1%
4.9% 2.9% 0.0%
3.9% 2.7% 0.0%
25.9% 14.3% 7.9%
14.7% 7.8% 4.1%
22.9% 11.6% 6.4%
0.0% 0.0% 0.0%
8.5% 5.6% 3.3%
0.0% 0.0% 0.0%
6.2% 4.0% 2.4%
12.5% 7.0% 3.9%
20.4% 11.3% 6.2%
13.4% 7.7% 3.0%
23.2% 15.2% 6.9%
24.7% 14.6% 7.2%
25.5% 15.4% 8.1%
26.1% 16.4% 6.5%
17.6% 8.9% 2.7%
8.8% 6.4% 4.3%

19.4% 12.9% 4.6%

22.7% 14.9% 8.9%
19.9% 12.9% 7.1%
12.3% 7.3% 4.7%
57.5% 51.0% 8.2%
0.0% 0.0% 0.0%
16.0% 15.0% 10.5%
32.8% 16.4% 10.4%
25.3% 17.5% 6.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
29.2% 14.8% 8.1%
34.0% 17.5% 9.8%
22.6% 11.7% 5.9%
33.9% 19.1% 9.7%
34.0% 20.2% 13.2%
34.5% 21.1% 12.8%
17.7% 8.3% 4.5%
0.0% 0.0% 0.0%
36.6% 23.4% 11.7%
0.0% 0.0% 0.0%
15.9% 6.6% 3.2%
8.2% 0.1% 0.0%
0.0% 0.0% 0.0%
21.0% 8.8% 3.1%
21.1% 10.7% 5.3%
19.7% 11.8% 6.8%
0.0% 0.0% 0.0%
0.7% 0.4% 0.2%
0.0% 0.0% 0.0%
5.7% 3.8% 2.4%
0.0% 0.0% 0.0%
11.9% 5.4% 2.5%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
33.5% 16.6% 10.3%
0.0% 0.0% 0.0%
26.6% 12.9% 4.4%
25.0% 12.7% 7.1%
22.3% 9.0% 6.1%
29.9% 20.1% 11.5%
19.7% 12.3% 7.4%
32.7% 13.4% 6.1%
22.3% 12.3% 7.5%
16.8% 8.6% 4.7%
7.2% 7.2% 0.0%
0.0% 0.0% 0.0%
9.4% 6.4% 4.8%
20.8% 9.0% 5.3%
26.9% 12.6% 6.5%
19.5% 11.6% 5.7%
8.9% 6.2% 4.0%
0.0% 0.0% 0.0%
4.8% 2.3% 1.2%
0.0% 0.0% 0.0%
7.2% 5.3% 4.2%
58.5% 57.2% 55.8%
0.0% 0.0% 0.0%
29.2% 15.2% 0.5%
16.8% 10.3% 6.7%
17.9% 12.0% 7.8%
39.1% 22.7% 16.9%
4.6% 2.6% 1.5%
0.0% 0.0% 0.0%
4.8% 1.0% 0.2%
32.5% 19.0% 11.9%
53.7% 22.2% 11.6%
24.4% 13.4% 8.5%
0.0% 0.0% 0.0%
21.3% 10.4% 5.3%
24.8% 12.4% 6.5%
82.2% 61.2% 14.4%
0.0% 0.0% 0.0%
27.2% 9.0% 2.3%

43.9% 21.9% 13.2%

0.0% 0.0% 0.0%
42.6% 28.8% 22.1%
0.0% 0.0% 0.0%
1.1% 0.0% 0.0%
0.0% 0.0% 0.0%
40.3% 16.7% 10.3%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
34.1% 18.7% 8.8%
0.0% 0.0% 0.0%
30.9% 13.4% -13.4%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
24.0% 13.0% 4.6%
25.7% 17.3% 9.0%
25.8% 16.1% 0.8%
26.3% 15.8% 8.8%
32.1% 18.4% 9.6%
28.7% 19.2% 9.2%
29.5% 17.6% 8.5%
35.4% 22.0% 11.1%
33.0% 15.8% 8.6%
0.0% 0.0% 0.0%
33.5% 18.3% 10.7%
0.0% 0.0% 0.0%
-3.0% -1.0% -0.2%
8.4% -7.0% -9.7%
0.0% 0.0% 0.0%
33.5% 17.7% 10.0%
25.7% 13.6% 21.8%
39.4% 22.5% 11.4%
42.5% 23.4% 11.9%
35.0% 18.2% 9.7%
35.5% 21.7% 12.2%
38.4% 21.7% 10.0%
59.1% 33.9% 32.5%
32.2% 20.5% 9.6%
18.2% 12.0% 9.3%
59.9% 41.7% 8.5%
49.3% 28.6% 2.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
42.3% 23.7% 12.7%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
 0.0% 0.0% 0.0%
-1.3% -3.5% -1.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
#DIV/0! #DIV/0! #DIV/0!
17.5% 6.1% 3.4%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
#DIV/0! #DIV/0! #DIV/0!
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.8% 2.6% 0.0%
10.7% 3.7% 2.1%
-12.6% -12.2% 0.0%
16.0% 0.0% 0.0%
2.3% 1.6% 1.2%
0.0% 0.0% 0.0%
20.7% 10.8% 4.8%
36.4% 16.1% 11.1%
22.7% 12.5% 6.8%
83.7% 0.0% 0.0%
23.5% 14.0% 8.6%
19.8% 7.8% 7.3%
43.7% 25.9% 15.7%
0.0% 0.0% 0.0%
11.4% 0.0% 0.0%
0.0% 0.0% 0.0%
21.8% 10.2% 5.7%
24.3% 11.0% 5.6%
13.9% 5.7% 2.8%
0.0% 0.0% 0.0%
6.4% 3.9% 0.9%
0.0% 0.0% 0.0%
14.9% 6.1% 3.1%
37.8% 19.4% 9.2%
13.1% 6.7% 3.2%
27.4% 15.0% 8.6%
0.0% 0.0% 0.0%
19.0% 8.9% -0.2%
0.0% 0.0% 0.0%
20.4% 9.6% 3.1%
127.6% 98.7% 74.5%
70.7% 35.5% 18.9%
104.3% 28.7% 3.2%
-1.5% -3.0% 2.5%
6.0% 1.0% 0.5%
3.3% 2.6% -1.3%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
7.7% 1.7% 0.4%
20.4% 11.5% 6.4%
22.9% 12.8% 7.7%
33.3% 13.4% 4.3%
107.6% 76.1% 54.8%
28.0% 17.7% 10.2%
49.4% 29.6% 12.7%
0.0% 0.0% 0.0%
36.9% 21.1% 11.9%
32.8% 18.3% 11.4%
19.4% 11.4% 7.0%
22.1% 13.3% 7.3%
26.5% 9.1% 4.5%
7.5% 4.0% 1.9%
4.8% 2.7% 1.0%
35.3% 17.6% 8.0%
0.0% 0.0% 0.0%
32.8% 16.9% 8.2%
44.8% 28.3% 13.2%
38.7% 28.7% 11.0%
23.5% 5.5% 0.1%
32.6% 21.3% 7.4%
27.2% 15.5% 7.7%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
35.9% 17.4% 11.0%
27.5% 16.6% 10.9%
38.0% 22.9% 11.5%
29.7% 15.8% 8.9%
26.8% 20.2% 12.6%
35.5% 12.7% 6.4%
10.2% 6.7% 3.6%
4.0% 3.6% 1.5%
2.4% 2.7% 0.4%
11.5% 7.5% 4.6%
0.0% 0.0% 0.0%
29.8% 12.9% 5.3%
0.0% 0.0% 0.0%
9.8% 4.7% 3.0%
0.0% 0.0% 0.0%
5.4% 5.2% 0.4%
0.0% 0.0% 0.0%
1.8% 1.0% 0.0%
57.6% 56.6% 4.4%
27.7% 15.1% 7.1%
24.6% 11.4% 5.4%
24.1% 12.0% 6.6%
6.8% 2.5% 1.2%
15.8% 9.0% 5.4%
32.5% 18.3% 8.5%
0.0% 0.0% 0.0%
29.7% 17.4% 8.7%
27.8% 14.1% 5.7%
0.0% 0.0% 0.0%
20.8% 12.5% 6.7%
0.0% 0.0% 0.0%
12.6% 1.6% 0.8%
 0.0% 0.0% 0.0%
15.7% 8.6% 5.4%
35.7% 18.0% 9.0%
28.8% 15.6% 6.9%
17.7% 11.9% 4.4%
25.1% 13.3% 5.3%
25.8% 13.3% 6.3%
20.1% 10.3% 3.0%
0.0% 0.0% 0.0%
23.0% 11.4% 4.8%
29.3% 18.2% 10.6%
29.0% 15.7% 8.7%
4.0% 2.2% 0.8%
19.5% 11.6% 0.0%
2.4% 1.6% 1.0%
4.7% 3.0% 1.7%
0.0% 0.0% 0.0%
3.6% 2.5% 1.7%
5.1% 3.5% 2.3%
25.0% 14.4% 7.9%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
23.6% 8.6% 5.2%
46.2% 10.9% -18.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
111.9% 64.5% 35.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
86.8% 43.1% 20.0%
0.0% 0.0% 0.0%
24.1% 12.2% 5.3%
24.2% 12.2% 5.7%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
19.2% 12.7% 7.6%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
0.0% 0.0% 0.0%
-0.1% -0.1% 0.0%
24.2% 12.2% 5.7%